Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Culturally Aware AET Non-Initiation Intervention
NCT05465408 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
Study Locations (11)
Massachusetts
- Massachusetts General Hospital Cancer Center — Boston
- Dana-Farber Cancer Institute — Boston
- Dana-Farber Cancer Institute at St Elizabeth's Medical Center — Brighton
- Emerson Hospital/MGH Cancer Center — Concord
- Mass General at North Shore Cancer Center — Danvers
- Dana-Farber Brigham Cancer Center - Foxborough — Foxborough
- Dana-Farber Cancer Institute - Merrimack Valley — Methuen
- Dana-Farber Brigham Cancer Center at Milford Regional Medical Center — Milford
- Mass General at Newton Wellesley Hospital — Newton
- Dana-Farber Brigham Cancer Center with South Shore Hospital — Weymouth
New Hampshire
- Dana-Farber/New Hampshire Onoclogy-Hematology — Londonderry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2024-11-20 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05465408
The ClinicalTrials.gov registry entry for NCT05465408 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 1,948 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention — of which Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05465408 reports 11 study locations spanning 2 distinct geographic areas — top geographies include Massachusetts, New Hampshire. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05465408 about?
NCT05465408 is a clinical study titled "Culturally Aware AET Non-Initiation Intervention". The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
What is the current status of trial NCT05465408?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2022-07-21. Estimated completion is 2024-11-20.
What conditions does trial NCT05465408 study?
This clinical trial studies the following conditions: Breast Cancer, Survivorship, Treatment Adherence, Treatment Refusal, Treatment Compliance. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05465408?
The interventions under investigation include: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05465408?
This trial is sponsored by Massachusetts General Hospital, which has 1,948 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05465408 being conducted?
This trial has 11 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.